Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Biostatistics: Overview01:20

Biostatistics: Overview

201
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
201
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

236
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
236
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

43
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
43
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

60
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
60
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

13
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
13
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

19
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
19

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Modeling single nucleus microglia across species identifies immune pathways and therapeutic candidates in Alzheimer's disease.

NPJ systems biology and applications·2026
Same author

Rumenomics: evaluation of rumen metabolites from healthy sheep identifies differentially produced metabolites across sex, age, and weight.

Animal microbiome·2026
Same author

Proteomic analysis reveals shared biological pathways linking acrolein to biomolecular changes in the acute phase of rat spinal cord injury.

bioRxiv : the preprint server for biology·2026
Same author

Risk of HSV-2 Acquisition Among Women with Bacterial Vaginosis: Systematic Review and Meta-Analysis.

Viruses·2026
Same author

Systems mapping of intra-donor, cross-tissue T cell clonal expansion and tissue adaptation in the gut-liver-blood axis.

Cell reports·2026
Same author

A ligand-centered framework for γδ T cell activation in colorectal cancer revealed by single-cell and transformer-based perturbation.

Frontiers in immunology·2026

相关实验视频

Updated: May 9, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.0K

微生物组多组数据的预测建模框架:潜伏交互变量效应 (LIVE) 建模.

Javier Munoz Briones1,2, Douglas K Brubaker3,4,5

  • 1Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA.

BMC bioinformatics
|April 29, 2025
PubMed
概括

隐性交互变量效应 (LIVE) 建模整合了多omics数据,以确定与疾病相关的关键微生物和代谢特征. 这种计算框架有助于解释复杂的宿主微生物群相互作用,以更好地预测和理解疾病.

关键词:
在 GLM 里面.IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD潜在的变量是潜在的变量.微生物组是一个微生物组.多种组合的多种组合.sPLS-DA 的时间.

更多相关视频

Author Spotlight: Advanced Enteroid Model for Studying Host-Pathogen Interactions
07:56

Author Spotlight: Advanced Enteroid Model for Studying Host-Pathogen Interactions

Published on: April 5, 2024

1.7K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.4K

相关实验视频

Last Updated: May 9, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.0K
Author Spotlight: Advanced Enteroid Model for Studying Host-Pathogen Interactions
07:56

Author Spotlight: Advanced Enteroid Model for Studying Host-Pathogen Interactions

Published on: April 5, 2024

1.7K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.4K

科学领域:

  • 微生物组研究 微生物组研究
  • 计算生物学 计算生物学
  • 系统生物学 系统生物学

背景情况:

  • 越来越多的多omics宿主微生物群数据需要先进的计算工具来解释.
  • 整合多样化的OMIC数据集对于理解复杂的生物系统和疾病机制至关重要.
  • 隐性交互变量效应 (LIVE) 建模为微生物多omics数据集成提供了一个新的框架.

研究的目的:

  • 介绍和验证微生物组多omics数据集成的潜在交互变量效应 (LIVE) 建模框架.
  • 开发LIVE的监督和无监督版本,能够结合共同变量意识.
  • 评估LIVE在使用现实世界微生物组和代谢数据集预测疾病状况方面的表现.

主要方法:

  • 使用稀疏的部分最小平方差异分析 (sPLS-DA) 潜在变量开发了一个受监督的 LIVE 模型.
  • 使用稀疏的主要组件分析 (sPCA) 主要组件开发了一个无监督的LIVE模型.
  • 将共变量意识纳入监督和无监督的LIVE模型.
  • 在克罗恩氏病和性结肠炎患者 (PRISM和LLDeep队列) 的转基因组和代谢学数据上应用和比较 LIVE.

主要成果:

  • LIVE在基准测试数据集上展示了与现有的多学科整合方法相比的一致和可比的性能.
  • 在克罗恩氏病和性结肠炎数据集中,LIVE显著地将特征相互作用的复杂性从数百万减少到不到20,000.
  • 该框架成功地将微生物和代谢特征的疾病预测能力与临床变量相关.

结论:

  • LIVE为现有的微生物多组组合方法提供了一种独特且互补的方法.
  • 在可解释性整合多omics数据与临床变量来预测疾病后果方面,LIVE提供了显著的优势.
  • 该框架有助于识别潜在疾病病原体的微生物组相关机制.